Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
63 studies found for:    "Short bowel syndrome"
Show Display Options
Rank Status Study
1 Withdrawn A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals
Conditions: Short Bowel Syndrome;   Short Gut Syndrome;   SBS;   Short Bowel;   Short Gut
Intervention: Drug: Opium Tincture USP Deodorized
2 Recruiting Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
Condition: Short Bowel Syndrome
Interventions: Drug: Teduglutide 0.05mg/kg;   Drug: Teduglutide 0.025 mg/kg;   Other: Standard of Care
3 Withdrawn Fiber Use in Pediatric Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Dietary Supplement: guar gum
4 Recruiting The Use of DPP-4 Inhibitors in Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Drug: Dipeptidyl peptidase-4 inhibitor
5 Completed Energy Metabolism in Patients With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention:
6 Recruiting A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention:
7 Withdrawn Pharmacokinetics of Citalopram in Patients With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Drug: Citalopram
8 Completed Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
Conditions: Bloodstream Infections;   Short Bowel Syndrome;   Development;   Nutrition;   Biological Markers
Interventions: Drug: Glutamine;   Dietary Supplement: L-alanine
9 Completed
Has Results
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Interventions: Drug: Placebo;   Drug: Teduglutide 0.05 mg/kg/d;   Drug: Teduglutide 0.1 mg/kg/d
10 Enrolling by invitation Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Interventions: Drug: GLP-2;   Drug: Placebo
11 Completed
Has Results
Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)
Condition: Short Bowel Syndrome
Intervention: Drug: teduglutide
12 Completed
Has Results
Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects
Condition: Short Bowel Syndrome
Interventions: Drug: teduglutide;   Drug: placebo
13 Completed Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Drug: rhGH
14 Terminated Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)
Condition: Short Bowel Syndrome
Intervention: Drug: Growth Hormone
15 Completed
Has Results
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
Condition: Short Bowel Syndrome
Interventions: Drug: teduglutide 0.05 mg/kg/d;   Drug: teduglutide 0.10 mg/kg/d
16 Completed
Has Results
A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Drug: teduglutide
17 Completed
Has Results
Short Bowel Syndrome and Teduglutide Versus Placebo
Condition: Short Bowel Syndrome
Interventions: Drug: Teduglutide;   Drug: Placebo
18 Completed
Has Results
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Intervention: Biological: Oral, live, pentavalent rotavirus vaccine; RotaTeq(R)
19 Unknown  Magnetic Resonance (MR) Enterography Assessment of Post Operative Small Bowel Length in Short Bowel Syndrome Patients
Condition: Short Bowel Syndrome
Intervention: Radiation: Barium follow-through and MR-enterography
20 Withdrawn Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
Condition: Short Bowel Syndrome
Interventions: Drug: Exenatide;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years